Article
Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling.
Oncogene - 21 Jan 2010
Hanker A B, Mitin N, Wilder R S, Henske E P, Tamanoi F, Cox A D, Der C J
Abstract excerpt
The Rheb1 and Rheb2 small GTPases and their effector mTOR are aberrantly activated in human cancer and are attractive targets for anti-cancer drug discovery. Rheb is targeted to endomembranes via its C-terminal CAAX (C=cysteine, A=aliphatic, X=terminal amino acid) motif, a substrate for posttranslational modification by a farnesyl isoprenoid. After farnesylation, Rheb undergoes two additional CAAX-signaled...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
